top of page


Our investigation group belongs to the Institute of Neurobiology of the National Autonomous University of Mexico (UNAM), located at the Juriquilla Campus in Querétaro. The works with iodized products and their function in different tissues since  2001. In 2005 we published for the first time that molecular iodine and not thyroid hormones or sodium iodide (present in iodized salt) was responsible for preventing Initiation and progression of breast cancer in a rat model. Later also in preclinical studies we show that the iodine supplement together with conventional chemotherapy sensitizes cancer cells and it is possible to reduce up to 4 times the amount of chemotherapy with anticancer effects. In addition to the mammary gland, our group has also analyzed other organs such as the prostate,  uterus, ovary,  pancreas, as well as the nervous and immune systems. We show that the supplement of this halogen helps in the treatment of benign pathologies such as prostatic hyperplasia, breast fibrosis, polycystic ovaries, metabolic syndrome, etc., and is an excellent supplement in the treatment of human breast cancer. We have expanded our investigation  spectrum and started studies in pets. As an adjunctive part of canine breast cancer therapy, iodine prior drug resistance and side effects.

We want to continue researching and discovering new effects and uses of this incredible element. We are related under strict supervision, our product to the general population as a  formulation and invites you to participate with this great project with your donation, through the UNAM Foundation Chapter Querétaro.





Therapeutic properties of iodine in extrathyroidal tissues.

Brenda Anguiano and Carmen Aceves

September 2011

Benign prostatic hyperplasia

José Antonio Alonso García / the lighthouse

february 2015

Molecular Iodine Has Extrathyroidal Effects as an Antioxidant, Differentiator, and Immunomodulator


27 January 2021

Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection

Yunuen Alfaro, et al.


Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammar y cancer.

Xóchitl Zambrano-Estrada, et al.


Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study

Aura Moreno-Vega, et al.

JULY 2019

bottom of page